The UK Herbal Supplements Market was valued at $136.76 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $182.40 Mn by 2030. The key drivers of this industry include rising consumer preference, increased supplement consumption, and the prevalence of a sedentary lifestyle. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife, NOW Foods, Botanic Supplements, and Dabur among others.
The UK Herbal Supplements Market was valued at $136.76 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $182.40 Mn by 2030.
Herbal supplements, also known as botanicals, are dietary supplements that contain one or more herbs. These products, which include herbal, botanical, or phytomedicines, are derived from plants or botanicals to promote health or treat illnesses. Herbal supplements are intended specifically for internal use and are commonly available in solid forms such as capsules, pills, tablets, and lozenges, but can also be found in liquid or powder forms. Some popular herbal supplements include Echinacea, Garlic, Ginkgo, Ginseng, St. John's Wort, Saw Palmetto, and Valerian.
In the UK, the pandemic has led to a 19% rise in supplement usage, with nearly 20 Mn adults UK now taking food supplements. Evening primrose oil (48.6%) and black cohosh (30.3%) are the most popular herbal supplements among UK consumers. The market is driven by significant factors like rising consumer preference, increased supplement consumption, and the prevalence of a sedentary lifestyle. However, limited scientific evidence, quality and safety concerns, and competition from conventional medicines restrict the growth and potential of the market.
Prominent players in this field include Himalaya Wellness, Herbalife, NOW Foods, Botanic Supplements, and Dabur among others.
Market Growth Drivers
Rising Consumer Preference: Consumers in the UK are increasingly favoring herbal supplements derived from plant sources due to their perceived holistic approach to wellness and connection to traditional healing methods. This trend serves as a market driver by stimulating demand for herbal supplements as a natural and culturally resonant choice for health maintenance and improvement.
Increased Supplement Consumption: The pandemic has led to a 19% rise in supplement consumption among adults in the UK, driving increased demand for herbal supplements as integral components of health and wellness regimens. This surge in usage acts as a market driver by boosting the popularity and sales of herbal supplements across the country.
Prevalence of Sedentary Lifestyle: The herbal supplement industry is experiencing growth due to the rising prevalence of sedentary lifestyles, greater consumption of nutritious meals, and increased healthcare awareness. Additionally, the uptick in health conditions resulting from unhealthy lifestyles has further fueled the demand for herbal supplements in the UK market.
Market Restraints
Limited Scientific Evidence: The absence of extensive clinical research and scientific validation for many herbal supplements may discourage healthcare professionals and consumers from fully adopting these products. This lack of evidence acts as a market restraint, limiting the credibility and acceptance of herbal supplements in the UK.
Quality and Safety Concern: Consumer concern regarding the effectiveness and safety of herbal supplements relative to conventional medicines can hinder adoption rates. This cautious approach serves as a market restraint for the herbal supplement industry in the UK, influencing consumer preferences and purchasing decisions.
Competition from Conventional Medicines: The widespread availability and popularity of conventional pharmaceutical products can compete with herbal supplements in certain uses, acting as a market restraint in the UK. This competition limits the market share and growth potential of herbal supplements as consumers may prefer or trust pharmaceutical options over herbal alternatives.
In the UK, herbal medicines must either obtain a Traditional Herbal Registration (THR) or a full Marketing Authorization (MA) to be legally sold. A THR signifies that the product has a longstanding history of traditional use and requires evidence of safety and quality rather than efficacy. The Medical and Healthcare Products Regulatory Agency (MHRA) evaluates the legal status of herbal products individually. The Herbal Medicines Advisory Committee (HMAC) advises the UK government on the safety and quality of herbal medicines, which may influence reimbursement decisions. Currently, the reimbursement framework for herbal supplements in the UK is still evolving.
Key Players
Here are some of the major key players in the UK Herbal Supplement Market:
1. Executive Summary
1.1 Product Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Government Regulation in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel and Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
6. Methodology and Scope
By Product Form
By Application
By Distribution Channel
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.